Literature DB >> 8827026

Encapsulated columnar-cell neoplasms of the thyroid. A report of four cases suggesting a favorable prognosis.

H L Evans1.   

Abstract

Four encapsulated thyroid neoplasms with columnar-cell features were studied. The patients were a 29-year-old man and three women aged 42, 60, and 83 years. The tumors measured from 1.2 to 8.0 cm in maximum dimension. All were completely surrounded by a thick capsule; three demonstrated invasion into the capsule (but no farther), whereas one (from the 60-year-old woman) did not. In addition to columnar-cell areas, all the neoplasms had areas with follicular and solid growth, in varying proportions. Although the growth pattern in the columnar-cell zones was usually papillary, nuclear characteristics of papillary carcinoma were not present in these areas or elsewhere. Follow-up on the four patients was 112, 51, 112, and 29 months, respectively, and none had any evidence of recurrence or metastasis. The findings suggest that encapsulated columnar-cell thyroid tumors have a much more favorable prognosis than those that are unencapsulated and invasive into adjacent thyroid or extrathyroid tissue.

Entities:  

Mesh:

Year:  1996        PMID: 8827026     DOI: 10.1097/00000478-199610000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

Review 1.  Follicular-patterned tumors of the thyroid: the battle of benign vs. malignant vs. so-called uncertain.

Authors:  Virginia A LiVolsi; Zubair W Baloch
Journal:  Endocr Pathol       Date:  2011-12       Impact factor: 3.943

Review 2.  Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma.

Authors:  Tyler Janovitz; Justine A Barletta
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

Review 3.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

4.  Columnar cell papillary thyroid carcinoma prognosis: findings from the SEER database using propensity score matching analysis.

Authors:  Shuntao Wang; Yiquan Xiong; Qiuyang Zhao; Haiping Song; Pengfei Yi; Chunping Liu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 5.  Familial nonmedullary thyroid neoplasia.

Authors:  H Rubén Harach
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  Cytomorphology of columnar cell variant of papillary carcinoma thyroid: A case report and review of the literature.

Authors:  Arijit Sen; Aasma Nalwa; Sandeep R Mathur; Deepali Jain; Venkateswaran K Iyer
Journal:  Cytojournal       Date:  2014-10-21       Impact factor: 2.091

Review 7.  Follicular-patterned afflictions of the thyroid gland: reappraisal of the most discussed entity in endocrine pathology.

Authors:  Zubair W Baloch; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

8.  TGFB, TGFB Receptors, Ki-67, and p27(Kip)l Expression in Papillary Thyroid Carcinomas.

Authors:  Ricardo V. Lloyd; Jorge A. Ferreiro; Long Jin; Tom J. Sebo
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

9.  Columnar Cell Carcinoma of the Thyroid: MIB-1 Immunoreactivity as a Prognostic Factor.

Authors:  Mitsuyoshi Hirokawa; Michio Shimizu; Takashi Fukuya; Toshiaki Manabe; Hiroshi Sonoo
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

Review 10.  Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer?

Authors:  Tobias Carling; Idris T Ocal; Robert Udelsman
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.